


Texas Weight Loss - North Austin operates under the medical direction of Dr. Joseph Sleiman, FAAFP, delivering prescription weight management programs centered on GLP-1 receptor agonist therapy in Austin, Texas. The clinic structures its approach around two primary peptide medications: semaglutide and tirzepatide, both FDA-approved for chronic weight management in adults with obesity or overweight status with weight-related comorbidities. Dr. Sleiman's board certification in family medicine informs the clinic's comprehensive screening process, which evaluates cardiovascular health, metabolic markers, and contraindications before initiating peptide therapy. Each patient undergoes baseline laboratory assessment including hemoglobin A1c, lipid panel, thyroid function, and renal markers to establish medical appropriateness for GLP-1 agonist treatment.
The North Austin clinic administers semaglutide as a once-weekly subcutaneous injection, typically initiating at 0.25 mg and titrating upward based on tolerance and response, with maintenance doses ranging from 1.7 mg to 2.4 mg weekly. Tirzepatide, a dual GIP/GLP-1 receptor agonist, follows a similar escalation protocol starting at 2.5 mg weekly, with therapeutic doses reaching 10 mg or 15 mg depending on individual response and side effect profile. The medical team monitors patients every four weeks during dose escalation phases, adjusting injection schedules based on gastrointestinal tolerance, rate of weight reduction, and metabolic improvements. Texas Weight Loss incorporates vitamin B12 supplementation into many treatment protocols, addressing potential deficiencies that may develop during caloric restriction and rapid weight loss phases. The clinic's nurse practitioners conduct regular check-ins to assess injection site reactions, nausea management, and adherence to the prescribed regimen.
Dr. Sleiman's Fellowship in the American Academy of Family Physicians reflects his commitment to evidence-based obesity medicine, and his clinical protocols align with current guidelines from the American Board of Obesity Medicine. The practice emphasizes that peptide therapy functions as one component within a broader metabolic intervention strategy. Patients receive individualized nutrition frameworks that account for macronutrient distribution, meal timing, and protein adequacy to preserve lean muscle mass during weight reduction. The clinic does not prescribe generic meal plans; instead, registered dietitians or trained staff work with patients to modify existing eating patterns in sustainable ways that complement the appetite suppression effects of GLP-1 medications. This approach addresses the common challenge of regaining weight after medication discontinuation by establishing behavioral patterns during the treatment phase.
Patients at the North Austin location can expect an initial consultation that includes medical history review, physical examination, discussion of weight loss goals, and education about peptide mechanism of action. The clinic explains that semaglutide and tirzepatide work by slowing gastric emptying, reducing appetite through central nervous system pathways, and improving insulin sensitivity. Follow-up visits occur monthly during active treatment, with each appointment including weight measurement, blood pressure assessment, and review of any adverse effects such as nausea, constipation, or injection site reactions. The medical team provides specific guidance on managing common side effects, including dietary modifications to minimize gastrointestinal symptoms and hydration strategies. Patients learn self-injection techniques during their first treatment visit, with staff demonstrating proper subcutaneous injection into the abdomen or thigh and reviewing needle disposal protocols.
Texas Weight Loss - North Austin offers both in-person appointments at their Austin facility and telehealth consultations for patients throughout Texas, expanding access to medical weight management for individuals who face transportation barriers or scheduling constraints. Telemedicine visits follow the same clinical protocols as in-office appointments, with patients completing laboratory work at local facilities and receiving prescriptions through partner pharmacies. The clinic's 4.9-star rating across 453 Google reviews reflects patient feedback on staff responsiveness, provider communication, and the structured nature of the weight management program. The front desk team coordinates insurance verification, prior authorization submissions for peptide medications, and scheduling of follow-up appointments. For Texas residents seeking medical supervision during GLP-1 therapy, the clinic provides ongoing monitoring that extends beyond simple prescription refills, incorporating metabolic tracking and adjustment of treatment parameters based on individual response patterns.
Dr. Joseph Sleiman· FAAFP
Dr. Joseph Sleiman, FAAFP
Medical Director
Dr. Joseph Sleiman has over 20 years of experience in medical weight loss and believes in helping patients achieve their goals through personalized plans.
Topics Mentioned in Reviews
Weight Loss Injections
Injections like Semaglutide and Tirzepatide to help with weight loss by suppressing appetite and boosting metabolism.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


